1. Home
  2. KTB vs GH Comparison

KTB vs GH Comparison

Compare KTB & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kontoor Brands Inc.

KTB

Kontoor Brands Inc.

HOLD

Current Price

$62.86

Market Cap

3.6B

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$102.95

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTB
GH
Founded
2018
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
14.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
KTB
GH
Price
$62.86
$102.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
21
Target Price
$96.38
$96.48
AVG Volume (30 Days)
751.2K
1.8M
Earning Date
11-03-2025
10-29-2025
Dividend Yield
3.37%
N/A
EPS Growth
N/A
N/A
EPS
3.88
N/A
Revenue
$2,833,659,000.00
$902,569,000.00
Revenue This Year
$20.46
$35.00
Revenue Next Year
$10.92
$26.80
P/E Ratio
$16.21
N/A
Revenue Growth
9.91
30.38
52 Week Low
$50.00
$29.91
52 Week High
$96.80
$112.43

Technical Indicators

Market Signals
Indicator
KTB
GH
Relative Strength Index (RSI) 31.72 57.55
Support Level $61.71 $96.28
Resistance Level $64.55 $103.17
Average True Range (ATR) 2.34 3.53
MACD -0.41 -0.70
Stochastic Oscillator 9.26 71.98

Price Performance

Historical Comparison
KTB
GH

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: